HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY

Most of the MALT-lymphoma of the stomach is generated in the antrum and it is macroscopically characterized by unclear boundaries, mucosa thickening or its ulceration. The MALToma generation is a many-phase process and it is a consequence of the chronic infection Helicobacter pylori. At an early sta...

Full description

Bibliographic Details
Main Authors: Snežana Jančić, Miljan Krstić, Vuka Katić, Stojan Radić, Slaviša Jančić
Format: Article
Language:English
Published: University in Nis, Faculty of Medicine 2002-09-01
Series:Acta Medica Medianae
Subjects:
Online Access:http://publisher.medfak.ni.ac.rs/2002-html/Br-5/HISTOPATOLOGIJA%20%20IMUNOHISTOHEMIJA.pdf
id doaj-2c0a5c84a2da4b118b773436f58fad5d
record_format Article
spelling doaj-2c0a5c84a2da4b118b773436f58fad5d2020-11-24T23:11:20ZengUniversity in Nis, Faculty of MedicineActa Medica Medianae0365-44782002-09-014156175HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY Snežana JančićMiljan KrstićVuka KatićStojan RadićSlaviša JančićMost of the MALT-lymphoma of the stomach is generated in the antrum and it is macroscopically characterized by unclear boundaries, mucosa thickening or its ulceration. The MALToma generation is a many-phase process and it is a consequence of the chronic infection Helicobacter pylori. At an early stadium, the tumor is limited to the stomach mucosa while its growth depends on the immunological stimulation through H. pylori while the regression starts after the eradication of this bacterium. However, the tumor can progress into an aggressive phase invading deeper layers of the gastric wall and, along with the dissemination into the local lymph nodes, into distant places as well. At an advanced stage, the stomach MALT lymphomas do not depend upon the H. pylori mediated stimulation; thus, they do not respond to the H. pylori eradication therapy. Finally, the boundary MALT lymphomas can be transformed into aggressive tumors of a high degree of malignity. Immunological and genetic factors intervene into the genesis of gastric MALT lymphomas, often synergetic in their effects. The immune response of the host to H. pylori induces the activity of the B-cell population.During this chronic inflammatory disease, the genome becomes unstable; thus, it is possible that the genetic abnormalities like trisomy should develop in the B cells. The changed B cell clone is subjected to clone expansion gradually forming the MALT lymphoma. Further genetic developments such as complete inactivation of the tumor suppressant genes (p53 and pl6) and possible activation of c-wyconcogene by trans location or other disturbances can lead to the transformation of the MALT lymphoma into the MALT lymphoma of a high malignity level. http://publisher.medfak.ni.ac.rs/2002-html/Br-5/HISTOPATOLOGIJA%20%20IMUNOHISTOHEMIJA.pdfMALT lymphomastomachmorphologytherapy
collection DOAJ
language English
format Article
sources DOAJ
author Snežana Jančić
Miljan Krstić
Vuka Katić
Stojan Radić
Slaviša Jančić
spellingShingle Snežana Jančić
Miljan Krstić
Vuka Katić
Stojan Radić
Slaviša Jančić
HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY
Acta Medica Medianae
MALT lymphoma
stomach
morphology
therapy
author_facet Snežana Jančić
Miljan Krstić
Vuka Katić
Stojan Radić
Slaviša Jančić
author_sort Snežana Jančić
title HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY
title_short HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY
title_full HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY
title_fullStr HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY
title_full_unstemmed HISTOPATHOLOGY, IMMUNOHISTOCHEMISTRY AND THE MALT LVMPHOMA THERAPY
title_sort histopathology, immunohistochemistry and the malt lvmphoma therapy
publisher University in Nis, Faculty of Medicine
series Acta Medica Medianae
issn 0365-4478
publishDate 2002-09-01
description Most of the MALT-lymphoma of the stomach is generated in the antrum and it is macroscopically characterized by unclear boundaries, mucosa thickening or its ulceration. The MALToma generation is a many-phase process and it is a consequence of the chronic infection Helicobacter pylori. At an early stadium, the tumor is limited to the stomach mucosa while its growth depends on the immunological stimulation through H. pylori while the regression starts after the eradication of this bacterium. However, the tumor can progress into an aggressive phase invading deeper layers of the gastric wall and, along with the dissemination into the local lymph nodes, into distant places as well. At an advanced stage, the stomach MALT lymphomas do not depend upon the H. pylori mediated stimulation; thus, they do not respond to the H. pylori eradication therapy. Finally, the boundary MALT lymphomas can be transformed into aggressive tumors of a high degree of malignity. Immunological and genetic factors intervene into the genesis of gastric MALT lymphomas, often synergetic in their effects. The immune response of the host to H. pylori induces the activity of the B-cell population.During this chronic inflammatory disease, the genome becomes unstable; thus, it is possible that the genetic abnormalities like trisomy should develop in the B cells. The changed B cell clone is subjected to clone expansion gradually forming the MALT lymphoma. Further genetic developments such as complete inactivation of the tumor suppressant genes (p53 and pl6) and possible activation of c-wyconcogene by trans location or other disturbances can lead to the transformation of the MALT lymphoma into the MALT lymphoma of a high malignity level.
topic MALT lymphoma
stomach
morphology
therapy
url http://publisher.medfak.ni.ac.rs/2002-html/Br-5/HISTOPATOLOGIJA%20%20IMUNOHISTOHEMIJA.pdf
work_keys_str_mv AT snezanajancic histopathologyimmunohistochemistryandthemaltlvmphomatherapy
AT miljankrstic histopathologyimmunohistochemistryandthemaltlvmphomatherapy
AT vukakatic histopathologyimmunohistochemistryandthemaltlvmphomatherapy
AT stojanradic histopathologyimmunohistochemistryandthemaltlvmphomatherapy
AT slavisajancic histopathologyimmunohistochemistryandthemaltlvmphomatherapy
_version_ 1725604878053539840